Dr. Sandor Jay Woren, D.O. Emergency Medicine - Emergency Medical Services Medicare: Not Enrolled in Medicare Practice Location: 5809 Rosemead Blvd, #b, Temple City, CA 91780 Phone: 818-613-5357 Fax: 818-559-6699 |
News Archive
The Drug Information Association (DIA) in Europe will host its 22nd Annual EuroMeeting from 8-10 March 2010 in Monaco. The DIA Annual EuroMeeting features more than 110 hot-topic sessions across 13 themes and attracts more than 3,000 professionals from the biopharmaceutical industry, contract service organisations, regulatory agencies, health ministries and academia, as well as patients and students worldwide.
Researchers and doctors at the Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed the first molecular test kit that can predict treatment and survival outcomes in kidney cancer patients. This breakthrough was recently reported in European Urology, the world's top urology journal.
A new staging system developed with a more accessible test to predict the chance of survival in patients living with light chain (AL) amyloidosis.
Among women with metastatic breast cancer, treatment with a drug that is biosimilar to the breast cancer drug trastuzumab resulted in an equivalent overall response rate at 24 weeks compared with trastuzumab, according to a study published online by JAMA.
› Verified 8 days ago